Structural basis of transcription arrest by coliphage HK022 nun in an Escherichia coli RNA polymerase elongation complex
Abstract
Coliphage HK022 Nun blocks superinfection by coliphage λ by stalling RNA polymerase (RNAP) translocation specifically on λΔNA.To provide a structural framework to understand how Nun blocks RNAP translocation, we determined structures of Escherichia coli RNAP ternary elongation complexes (TECs) with and without Nun by single-particle cryo-electron microscopy. Nun fits tightly into the TEC by taking advantage of gaps between the RNAP and the nucleic acids. The C-terminal segment of Nun interacts with the RNAP β and β’ subunits inside the RNAP active site cleft as well as with nearly every element of the nucleic-acid scaffold, essentially crosslinking the RNAP and the nucleic acids to prevent translocation, a mechanism supported by the effects of Nun amino acid substitutions. The nature of Nun interactions inside the RNAP active site cleft suggests that RNAP clamp opening is required for Nun to establish its interactions, explaining why Nun acts on paused TECs.
Data availability
-
CryoEM structure of HK022 Nun - E. coli RNA polymerase elongation complexPublicly available at the RCSB Protein Data Bank (accession no: 5UP6).
-
CryoEM structure of HK022 Nun - E. coli RNA polymerase elongation complexPublicly available at the EMBL-EBI Protein Data Bank in Europe (accession no: EMD-8584).
-
CryoEM structure of crosslinked E.coli RNA polymerase elongation complexPublicly available at the RCSB Protein Data Bank (accession no: 5UPA).
-
CryoEM structure of crosslinked E.coli RNA polymerase elongation complexPublicly available at the EMBL-EBI Protein Data Bank in Europe (accession no: EMD-8585).
-
CryoEM structure of E.coli RNA polymerase elongation complexPublicly available at the RCSB Protein Data Bank (accession no: 5UPC).
-
CryoEM structure of E.coli RNA polymerase elongation complexPublicly available at the EMBL-EBI Protein Data Bank in Europe (accession no: EMD-8586).
-
Crystal Structure Analysis of the E.coli holoenzymePublicly available at the RCSB Protein Data Bank (accession no: 4LJZ).
-
Crystal structure of the T. thermophilus RNAP polymerase elongation complex with the NTP substrate analogPublicly available at the RCSB Protein Data Bank (accession no: 2O5J).
Article and author information
Author details
Funding
National Institutes of Health (R35 GM118130)
- Seth A Darst
National Institutes of Health (R01 GM037219)
- Max E Gottesman
National Institutes of Health (P41 GM103314)
- Brian T Chait
Public Health Research Institute Research Support grant
- Arkady Mustaev
National Institutes of Health (P41 GM109824)
- Brian T Chait
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2017, Kang et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,802
- views
-
- 790
- downloads
-
- 118
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
Mutations in the kinase and juxtamembrane domains of the MET Receptor Tyrosine Kinase are responsible for oncogenesis in various cancers and can drive resistance to MET-directed treatments. Determining the most effective inhibitor for each mutational profile is a major challenge for MET-driven cancer treatment in precision medicine. Here, we used a deep mutational scan (DMS) of ~5764 MET kinase domain variants to profile the growth of each mutation against a panel of 11 inhibitors that are reported to target the MET kinase domain. We validate previously identified resistance mutations, pinpoint common resistance sites across type I, type II, and type I ½ inhibitors, unveil unique resistance and sensitizing mutations for each inhibitor, and verify non-cross-resistant sensitivities for type I and type II inhibitor pairs. We augment a protein language model with biophysical and chemical features to improve the predictive performance for inhibitor-treated datasets. Together, our study demonstrates a pooled experimental pipeline for identifying resistance mutations, provides a reference dictionary for mutations that are sensitized to specific therapies, and offers insights for future drug development.
-
- Biochemistry and Chemical Biology
- Genetics and Genomics
RNA binding proteins (RBPs) containing intrinsically disordered regions (IDRs) are present in diverse molecular complexes where they function as dynamic regulators. Their characteristics promote liquid-liquid phase separation (LLPS) and the formation of membraneless organelles such as stress granules and nucleoli. IDR-RBPs are particularly relevant in the nervous system and their dysfunction is associated with neurodegenerative diseases and brain tumor development. Serpine1 mRNA-binding protein 1 (SERBP1) is a unique member of this group, being mostly disordered and lacking canonical RNA-binding domains. We defined SERBP1’s interactome, uncovered novel roles in splicing, cell division and ribosomal biogenesis, and showed its participation in pathological stress granules and Tau aggregates in Alzheimer’s brains. SERBP1 preferentially interacts with other G-quadruplex (G4) binders, implicated in different stages of gene expression, suggesting that G4 binding is a critical component of SERBP1 function in different settings. Similarly, we identified important associations between SERBP1 and PARP1/polyADP-ribosylation (PARylation). SERBP1 interacts with PARP1 and its associated factors and influences PARylation. Moreover, protein complexes in which SERBP1 participates contain mostly PARylated proteins and PAR binders. Based on these results, we propose a feedback regulatory model in which SERBP1 influences PARP1 function and PARylation, while PARylation modulates SERBP1 functions and participation in regulatory complexes.